Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	64.65	115.59	70.20
Graham Fair Price	-20.73	24.28	30.62
PEG	-92.08	0.38	-4.80
Price/Book	32.18	4.96	3.75
Price/Cash Flow	-8.72	83.13	91.07
Prices/Earnings	109.23	-64.51	30.83
Price/Sales	38.95	26.57	19.12
Price/FCF	-8.72	83.13	91.07
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.05	0.72	0.73
Operating Margin	-18.40	0.19	0.23
ROA	-39.17	-0.01	0.02
ROE	0.03	-0.02	-36.82
ROIC	0.03	0.02	-5.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	-0.19	-51.86
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.15	-0.23	48.75
EPS QOQ	-0.06	-1.70	-2541.04
FCF QOQ	0.89	0.45	-49.81
Revenue QOQ	0.09	-0.05	-46.06
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	75.14	87.25	16.11
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.15	0.18	23.60
Quick Ratio	1.25	1.12	-10.49
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.01	36.91	-0.27
Cash	9.67	11.66	20.52
Capex	-0.16	-0.16	1.66
Free Cash Flow	1.52	2.20	44.42
Revenue	7.26	6.89	-5.12
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.25	-5.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.29	0.16	-42.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating